# US 2020/0390938 A1 · Intravascular retrievable cell delivery system

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0390938 A1
- Document ID: US20200390938A1
- Status: Published application
- Kind: A1
- Application number: 16/612,540
- Filed: 2018-05-11
- Published: 2020-12-17
- Earliest claimed: 2017-05-11
- Assignees: Northwestern University
- Applicants: Northwestern University
- Inventors: Guillermo A. Ameer; Paul D. Puglisi
- Web page: https://patentgrep.com/patent/US20200390938A1

## CPC

- A61F 2/06: Blood vessels
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61F 2/022: {Artificial gland structures using bioreactors (hemodialysis A61M1/16; hemofiltration A61M1/34; other extracorporeal blood treatment A61M1/36)}
- A61L 27/3808: {Endothelial cells}
- A61L 27/3886: {comprising two or more cell types}
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- C12N 5/0677: {Three-dimensional culture, tissue culture or organ culture; Encapsulated cells}
- A61F 2/04: Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95)
- A61F 2/07: Stent-grafts
- A61F 2250/0039: differing in diameter
- A61L 2300/43: Hormones, e.g. dexamethasone
- A61L 2300/64: Animal cells
- A61L 2400/06: Flowable or injectable implant compositions
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided herein are intravascular retrievable cell delivery systems and methods of use thereof for cell transplantation.

## Claims

### Claim 1

A device for the intravascular transplantation of cells comprising:
(a) an outer graft, the outer graft comprising an inner lumen and an outer wall, wherein the outer graft comprises first and second terminal portions and a central expanded portion, the central portion having a greater inner cross-sectional area than the terminal portions;
(b) an inner element, the inner element comprising an inner lumen and an outer wall;
wherein the inner element comprises a cross-sectional size and shape along its entire length that allows the inner element to fit within the lumen of the outer graft; and
wherein the inner element is configured for insertion into the inner lumen of the outer graft, and wherein when the inner element resides within the outer graft, a void exists between all or a portion of the inner element and all or a portion of the outer graft.

### Claim 2 (depends on 1)

The device of claim 1, wherein the inner element is an inner graft.

### Claim 3 (depends on 1)

The device of claim 1, wherein when the inner element waft resides within the outer graft, the inner element extends from the first terminal portion of the outer graft to the second terminal portion of the outer graft.

### Claim 4 (depends on 3)

The device of claim 3, wherein the outer wall of the inner element approximates the inner cross-sectional area of the terminal portions of the outer graft, and wherein the inner lumen of the outer graft and the outer wall of the inner element are configured to interact to hold the inner element in place within the outer graft.

### Claim 5 (depends on 1)

The device of claim 1, wherein the inner element is an inner stent.

### Claim at position 6

-7. (canceled)

### Claim 8 (depends on 1)

The device of claim 1, wherein the outer wall of the outer graft is configured for contacting the inner lumen of the vasculature of a subject.

### Claim 9

(canceled)

### Claim 10 (depends on 1)

The device of claim 1, wherein the inner lumen of the inner element is configured to allow blood to flow through the inner lumen, when inserted into the vasculature of a subject.

### Claim 11 (depends on 1)

The device of claim 1, wherein the inner element is permeable or semipermeable.

### Claim 12 (depends on 11)

The device of claim 11, wherein the inner element is configured to allow fluids, nutrients, peptides, and/or proteins pass between the inner lumen of the inner element and the void between the inner element and the outer graft.

### Claim 13 (depends on 1)

An intravascular delivery system comprising:
(a) the device of claim 1, wherein the inner element resides within the outer graft; and
(b) a carrier material, wherein the carrier material resides within the void between the inner element and the outer graft.

### Claim 14 (depends on 13)

The intravascular delivery system of claim 13, further comprising:
(c) a cargo embedded with the carrier material.

### Claim 15 (depends on 14)

The intravascular delivery system of claim 14, wherein the cargo is selected from transplantable cells or a therapeutic agent.

### Claim 16 (depends on 15)

The intravascular delivery system of claim 15, wherein the cargo comprises transplantable cells selected from islets cells, stem cells, hepatocytes, and renal tubular cells.

### Claim 17 (depends on 15)

The intravascular delivery system of claim 15, wherein the cargo comprises a therapeutic agent selected from insulin, a hormone, and an anticoagulant.

### Claim 18 (depends on 13)

The intravascular delivery system of claim 13, wherein the carrier material is a biocompatible polymer-based material.

### Claim at position 18

-20. (canceled)

### Claim 21 (depends on 18)

The intravascular delivery system of claim 18, wherein the carrier material comprises a thermoresponsive polymer.

### Claim 22 (depends on 21)

The intravascular delivery system of claim 21, wherein the carrier material comprises poly(polyethyleneglycol citrate-co-N isopropylacrylamide) (PPCN).

### Claim 23 (depends on 15)

The intravascular delivery system of claim 15, wherein the transplantable cells are pancreatic islet cells and the inner graft is permeable to insulin.

### Claim 24 (depends on 13)

The intravascular delivery system of claim 13, further comprising endothelial cells adhered to the inner lumen of the inner graft.

### Claim 25 (depends on 13)

A method comprising implanting an intravascular delivery system of claim 13 into the vasculature of a subject.

### Claim 26

(canceled)
